Product Information
14389-1-AP targets BIK in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag5859 Product name: Recombinant human BIK protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-134 aa of BC001599 Sequence: MSEVRPLSRDILMETLLYEQLLEPPTMEVLGMTDSEEDLDPMEDFDSLECMEGSDALALRLACIGDEMDVSLRAPRLAQLSEVAMHSLGLAFIYDQTEDIRDVLRSFMDGFTTLKENIMRFWRSPNPGSWVSCE Predict reactive species |
| Full Name | BCL2-interacting killer (apoptosis-inducing) |
| Calculated Molecular Weight | 18 kDa |
| GenBank Accession Number | BC001599 |
| Gene Symbol | BIK |
| Gene ID (NCBI) | 638 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen Affinity purified |
| UNIPROT ID | Q13323 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
BIK, also named as NBK, BIP1 and BP4, is a pro-apoptotic BCL-2 family member and is the founding member of a subfamily of pro-apoptotic proteins known as BH3-alone proteins. It is a transcript that is upregulated during induction of apoptosis.
Publications
What published studies show
The BIK Polyclonal antibody (Cat# 14389-1-AP) has 1 citation to date. It was used in a Western Blot study published in Scientific Reports (2025), investigating the oncogenic role of TIMM8A in breast cancer cells. The research falls within the fields of oncology and cancer cell biology, specifically exploring mechanistic insights into tumor progression.
| Species | Application | Title |
|---|---|---|
Sci Rep The oncogenic role of TIMM8A in cancer and the mechanistic insights into the function in breast cancer cells |
